In India, where the doctor-to-patient ratio places significant pressure on clinical teams, hospitals consistently work to enhance efficiency, resilience, and reliability, especially in high-risk environments. Chronic conditions such as diabetes, cardiovascular disease, and maternal health represent a substantial share of India’s healthcare burden. In such scenarios, digital twins serve as a common intelligence layer that consolidates clinical evidence, provides likely outcomes, and helps teams align on a unified, data-backed plan.
India’s population has one of the most complex genetic landscapes in the world, making it an ideal testing ground for precision therapeutics. Digital twins can model drug responses tailored to specific Indian genetic profiles. As India strengthens its digital health infrastructure and expands remote monitoring, digital twins also support meaningful patient engagement by strengthening adherence, enabling timely intervention, and encouraging patients to take an active role in managing their health.
【MORE】